Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

MND Trial Completes Enrolment of First Patient Cohort

MND Trial Completes Enrolment of First Patient Cohort (final)

Category: News & Announcements 2022By PharmAust December 2, 2022

Related posts

Fireside chat with Dr Kim
December 23, 2022

PharmAust Canine Trial Update
December 20, 2022

PharmAust Receives R&D Tax Incentive Refund
December 12, 2022

PhamAust Webinar
November 17, 2022

PhamAust AGM 2022
November 11, 2022

PharmAust doses first patient with MPL in motor neurone disease trial
October 3, 2022

Recent Articles

Notice of General Meeting
May 26, 2023
Motor Neurone Disease Clinical Trial Update
May 22, 2023
Progress update on Phase 1/2 MND interim analysis
May 16, 2023
Independent tests show MPL retains long-term shelf-life
May 10, 2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

pharmaust Follow

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions